Patient, center and geographic characteristics of nationally placed livers

Am J Transplant. 2012 Apr;12(4):947-53. doi: 10.1111/j.1600-6143.2011.03962.x. Epub 2012 Feb 2.

Abstract

Once a liver offer has been refused locally and regionally, it is offered nationally. We characterized nationally (n = 1567) versus locally (n = 19 893) placed grafts from adult, nonfulminant, deceased donor liver transplants (LT) from 2/1/05 to 1/31/10. Donors of nationally versus locally placed livers differed by age (50 vs. 42 years), positive HCV antibody (11 vs. 2%) and death from stroke (51 vs. 42%) (p < 0.001 for all). Recipients of nationally versus locally placed livers differed by LT-MELD (20 vs. 24), rates of ascites (35 vs. 37%), encephalopathy (12 vs. 15%), hepatocellular (17 vs. 24%) and nonhepatocellular exceptions (6 vs. 11%) (p ≤ 0.03 for all). Six (5%) centers utilized 64% of the nationally placed grafts while 43 (38%) centers accepted zero during the 5-year period; all high volume centers used ≥1. Compared to local distribution, transplantation with a nationally placed liver was associated with a similar adjusted risk of graft (HR, 0.99; 95% CI, 0.86-1.14) and patient (HR, 0.98; 95% CI, 0.84-1.14; p = 0.77) survival. In conclusion, utilization of nationally placed livers is highly concentrated in very few centers, with no increased adjusted risk of graft loss. These findings provide the foundation for a more informed discussion about changing our current liver allocation and distribution policies.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Donor Selection*
  • End Stage Liver Disease / epidemiology*
  • End Stage Liver Disease / therapy
  • Ethnicity
  • Female
  • Graft Survival
  • Hospitals / statistics & numerical data*
  • Humans
  • Liver Transplantation / mortality*
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Practice Patterns, Physicians'*
  • Risk Factors
  • Survival Rate
  • Tissue Donors / supply & distribution*
  • Tissue and Organ Procurement*
  • United States / epidemiology